Myonex
- Company typePrivate
- Founded1931
- HeadquartersHorsham, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
Myonex firmographics
Firmographics- Name
- Myonex
- Legal name
- Myonex, LLC
- Website
- https://myonex.com
- Company type
- Private
- Founded year
- 1931
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Myonex industry classification
Industry- Product category
- Clinical Trial Supply Services
- NAICS
- Pharmaceutical and Medicine Manufacturing (32541), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Prescription Pharmaceutical (Rx) Wholesale Distribution (CRAOAHAA)
- akta.pro secondary industry
- Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers) (IMALAIAH)
Keywords
Where Myonex is headquartered
LocationHeadquarters
- HQ city
- Horsham
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
Myonex business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Operations, Supply Chain, Marketing or Sales, Technology or R&D
Revenue model
- Clinical Trial Supply Services: Myonex provides integrated clinical trial supply services including comparator and commercial drug sourcing, clinical packaging, labeling, and distribution, pharmacy services (including compounding), and bioservices. These services are typically delivered under multi-year project contracts with pharmaceutical and biotech sponsors and CROs.
- Commercial Pharmaceutical Packaging Services: Contract commercial packaging services for pharma, biotech, and medical device companies including primary packaging (blistering and bottling), secondary packaging, serialization, and repackaging. Revenue generated through project-based and ongoing service agreements.
- Drug and Ancillary Sourcing: Sourcing of comparator drugs, commercial medications, and ancillary equipment and supplies for clinical trials. Myonex leverages exclusive manufacturer partnerships to provide cost savings and supply continuity for clients.
- Consulting Services: Pharmacist consulting services, supply chain optimization consulting, and ultra-cold chain consulting delivered by Myonex experts. These services support clinical trial planning, execution, and cold chain management.
- CTRx® Solution: Prescription card services, global pharmacy dispensing, and centralized local drug supply combined into a single patient-centric solution. Eliminates upfront bulk purchasing and reduces drug waste for sponsors.
Go-to-market motion1 record
Distribution channels5 records
Marketing channels7 records
Myonex product offering
Product offeringCore offering
Myonex provides integrated clinical trial supply and commercial pharmaceutical services to pharmaceutical sponsors, biotech companies, and CROs globally. Its offerings include drug sourcing, clinical packaging, labeling, distribution, pharmacy services (including compounding), bioservices with ultra-cold storage, commercial packaging, and consulting. The flagship solution CTRx® combines prescription card services, global pharmacy dispensing, and centralized local drug supply to reduce drug waste and trial costs.
Product overview
Myonex is an integrated clinical trial supply and commercial pharmaceutical services company offering a comprehensive suite of services across the drug development lifecycle. The portfolio centers on CTRx® as the core patient-centric solution, which uniquely combines prescription card services, global pharmacy dispensing, and centralized local drug supply. Supporting services include Clinical Packaging, Labeling & Distribution for IMPs and NIMPs; Drug & Ancillary Sourcing with exclusive manufacturer partnerships; US Pharmacy Services (including SaveWay Compounding Pharmacy for sterile/non-sterile compounding and DtP capabilities); Bioservices for ultra-cold storage and ATMP supply chain management; Commercial Packaging with serialization capabilities; and Biologicals & ATMPs Supply Chain services. The consulting arm provides Pharmacist Consulting, Supply Chain Optimization (with advanced forecasting simulation), and Ultra-Cold Chain Consulting. All services are designed to reduce time, cost, and complexity for pharmaceutical, biotech, and CRO partners.
Differentiator
Problem solved
Functional benefit
Brands
- CTRx: A combination of prescription card services, global pharmacy dispensing, and centralized local drug supply in a single solution for clinical trials.
- myCTcentral
Products and services
- CTRx® Clinical trial patient solutions combining prescription card services, global pharmacy dispensing, and centralized local drug supply in a single integrated solution designed to eliminate drug waste and reduce costs.
- Clinical Packaging, Labeling & Distribution End-to-end clinical trial packaging, labeling, and distribution services including primary packaging (blistering, bottling), secondary packaging, JIT labeling, blinding options, and global distribution to sites or direct-to-patient.
- Drug & Ancillary Sourcing Comparator drug sourcing and ancillary supplies for clinical trials including exclusive manufacturer partnerships, limited distribution drugs access, REMS programs, and global depot network for pharmaceutical and biotech companies.
- Pharmacy Services (US 50-State) Comprehensive US pharmacy capabilities including SaveWay Compounding Pharmacy for sterile and non-sterile compounding, IMP dispensing, direct-to-patient shipping, and decentralized clinical trial support across all 50 states.
- Bioservices Cold and ultra-cold biostorage services for biological materials including ATMP supply chain management, cell and gene therapy logistics, biorepository, and cryopreservation from -80°C to -196°C.
- Commercial Packaging Contract pharmaceutical packaging services for commercial products including primary packaging (blistering, bottling), secondary packaging, serialization, and aggregation for pharma, biotech, and medical device companies.
- Biologicals & ATMPs Supply Chain Specialized cold chain storage, packaging, and logistics for biologicals and Advanced Therapy Medicinal Products (ATMPs) including immunotherapies, vaccines, CAR-T cells, and gene therapies with temperatures from 2°C-8°C to -196°C.
- Pharmacist Consulting Services Expert pharmacist collaboration for clinical trial protocol navigation including pharmacy manuals, direct-to-patient operationalization, and IDS pharmacist support.
- Supply Chain Optimization Consulting
- Ultra-Cold Chain Consulting Consulting, audits, and training services for biostorage and ultra-low temperature environments including cryopreservation expertise, staff training (Qualiopi certified), and biobank design support.
Quantifiable outcome
- Up to 65% cost savings in clinical trial drug supply compared to traditional central sourcing models
- +3 more outcomes
Companies that use Myonex
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Myonex technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Myonex partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- DebiopharmcoreMyonex designed and is executing a hybrid local and central sourcing and labeling strategy for Debiopharm's Phase III trial (Debio 4126-301) across 70 sites in 20 countries. The collaboration demonstrates Myonex's integrated clinical supply capabilities, combining CTRx local sourcing, central JIT labeling, and Direct-to-Patient distribution.
- The Leukemia & Lymphoma Society (LLS)coreMyonex was selected by LLS as the preferred partner to support patients participating in the LLS-sponsored Beat AML Master Clinical Trial through its CTRx solution. This partnership helps ensure uninterrupted access to commercial medications and comprehensive patient financial assistance for blood cancer patients enrolled in the trial.
- AdalvocoreMyonex and Adalvo have an expanded exclusive clinical trial supply partnership under which Myonex is the exclusive global provider of Adalvo products for clinical trial use. The partnership was further expanded to include multiple new assets for global markets. This partnership enables Myonex to provide pharmaceutical companies, biotechs, CROs, and other service providers with access to Adalvo's generic and biosimilar medicines for clinical trials, delivering cost reductions, supply continuity, and timely availability.
- DebiopharmcoreDebiopharm partnered with Myonex for the Debio 4126-301 Phase III trial, utilizing Myonex's hybrid sourcing solution combining central Just-In-Time labeling in Europe and CTRx local sourcing across 6 global countries including the US, Spain, France, UK, Brazil, and Israel.
- Strategic Depot Partner NetworkminorMyonex maintains a strategic partner depot network spanning countries in Europe, North America, Latin America, Asia Pacific, Middle East, and Africa to extend its storage and distribution reach beyond its owned facilities.
Scale indicators10 records
Recent moves10 records
Expansion highlights6 records
Myonex competitors and assessment
Company assessmentDirect peers
- Marken (UPS Healthcare): UPS-owned clinical trial supply chain and logistics specialist covering drug distribution, cold chain, and Direct-to-Patient services. Comparable to Myonex's clinical distribution and bioservices capabilities, with similar sponsor base.
- Sharp Packaging (Clinigen): Contract packaging provider for pharma and biotech including clinical and commercial packaging, serialization, and compliance packaging. Directly comparable to Myonex's commercial and clinical packaging operations.
- Catalent: Global pharma services provider offering clinical and commercial supply, packaging, biologics, and cell/gene therapy services. Closest large-scale direct peer to Myonex's integrated clinical supply and commercial packaging model, though substantially larger in scale.
- PCI Pharma Services: Contract pharma services provider specializing in clinical and commercial packaging, serialization, and global supply chain. Directly competes with Myonex across integrated packaging, labeling, and distribution services.
- Almac Group: Privately held global contract pharma services company offering clinical trial supply, packaging, labeling, distribution, and commercial services. Closely aligned with Myonex across clinical packaging, blinding, and global distribution services.
Broad incumbents
- Recipharm: European-headquartered CDMO offering contract development, manufacturing, and supply services to pharma and biotech. Overlaps with Myonex's commercial packaging and pharma services in Europe, particularly post-Creapharm.
- Thermo Fisher Scientific (Patheon/CDMO): Diversified life sciences incumbent whose Patheon pharma services segment spans clinical supply, commercial packaging, and CDMO capabilities. Overlaps with Myonex's clinical packaging and distribution offering but as part of a much broader portfolio.
- IQVIA: Largest CRO with extensive clinical trial operations and ancillary clinical supply capabilities. Broad incumbent competing for the same pharma and biotech sponsor budgets as Myonex, though with vastly broader service breadth.
- Eurofins CDMO: Diversified testing and contract pharma services group offering CDMO, packaging, and analytical services. Comparable to Myonex's commercial packaging and bioservices offerings as part of a broader services portfolio.
Emerging players
- Bionova Scientific: Biologics-focused CDMO and pharma services firm with growing clinical and commercial capabilities. Comparable emerging player to Myonex in biologics packaging and supply services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Myonex social profiles
Digital presenceMyonex compliance and trust
Trust signalCompliance9 records
Myonex financial estimates
Financial estimateRevenue estimate
Valuation estimate
Myonex leadership team
Management profileNumber of profiles
Profiles11 records
Myonex subsidiaries and ownership
Company hierarchySubsidiaries6 records
Myonex funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Myonex M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Myonex
What does Myonex do?
Myonex provides integrated clinical trial supply and commercial pharmaceutical services to pharmaceutical sponsors, biotech companies, and CROs globally. Its offerings include drug sourcing, clinical packaging, labeling, distribution, pharmacy services (including compounding), bioservices with ultra-cold storage, commercial packaging, and consulting. The flagship solution CTRx® combines prescription card services, global pharmacy dispensing, and centralized local drug supply to reduce drug waste and trial costs.
Is Myonex a public or private company?
Myonex is a private company. It is classified as family owned and is currently operating.
When was Myonex founded?
Myonex was founded in 1931. It employs 101 to 250 people.
Where is Myonex based?
Myonex is headquartered in Horsham, United States, in the North America region.
How does Myonex make money?
Five revenue lines are on record. Clinical Trial Supply Services are the primary driver. The others are commercial Pharmaceutical Packaging Services, drug and Ancillary Sourcing, consulting Services and CTRx® Solution.
Who are Myonex's main competitors?
Direct peers on record are Marken (UPS Healthcare), Sharp Packaging (Clinigen), Catalent, PCI Pharma Services and Almac Group. Broad incumbents are Recipharm, Thermo Fisher Scientific (Patheon/CDMO), IQVIA and Eurofins CDMO. Bionova Scientific is listed as an emerging player.
Does Myonex have an API?
No public API is recorded for Myonex.
What industry is Myonex in?
Myonex's product category is Clinical Trial Supply Services. Its primary akta.pro industry code is CRAOAHAA, Prescription Pharmaceutical (Rx) Wholesale Distribution, with a secondary code of IMALAIAH, Unit-Dose & Compliance Packaging (Sachets, Strip Packs, Pill Organizers). Its NAICS code is 32541 and its SIC code is 5122.